Journal of Women's Health

Obstetrics & gynaecology

Elagolix reduces menstrual bleeding from most common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States—benign tumors that disproportionately affect African-Americans, an international clinical trial ...

Diseases, Conditions, Syndromes

Speeding progress in migraine requires unraveling sex differences

To decrease the substantial health and economic burden of migraine on individuals and society, researchers need to examine and address how the disease differs between women and men, according to a report from the Society ...

page 5 from 18